Law firm or agent

HENRY HADAD

Save Like

2,349 applicationsfiled 2006 to 2026

Allowance rate

71%

−4 pts vs the USPTO range 69% to 73%

Rejections before allowance

1.1

−0.5 vs the USPTO

Months to first action

13.1 mo

−5.5 vs the USPTO

Needed an RCE

12%

−16 pts vs the USPTO

Timeline

Applications by filing year: drag across the years to study a period

Allowed in green, abandoned in red, pending in grey. The figures above and the charts that can be recomputed by filing year follow the span you pick.

Compared with the office

Against every applicant before the USPTO

Unlock the comparison with the officeFree with an account. No card needed.

Create a free account

Trend

Allowance by filing year

Unlock the trendIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Domains

Where the applications fall

CPC subclasses

C07D Heterocyclic compounds1,086 apps

C07K Peptides527 apps

A61K Medical preparations440 apps

G01N Investigating or analysing materials59 apps

A61P Therapeutic activity of compounds54 apps

C12N Microorganisms or enzymes34 apps

Art units

1624389 apps

1625284 apps

1626244 apps

1647211 apps

1646157 apps

1644135 apps

Examiners met

The examiners seen most, and how it went with each

Ilia I Ouspenski77 apps

77%

Bruck Kifle76 apps

80%

Fozia M Hamud73 apps

44%

Venkataraman Balasubramanian72 apps

85%

Docket Central63 apps

n/a

Brenda Libby Coleman52 apps

83%

Dong Jiang46 apps

67%

Paul V Ward40 apps

84%

Bars show the share of decided applications that were allowed.

Unlock the examiners this firm meetsIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Who they file for

Clients with the most applications

BRISTOL-MYERS SQUIBB COMPANY1,396 apps

77%

ZymoGenetics, Inc.118 apps

58%

Mirati Therapeutics, Inc.59 apps

83%

E. R. SQUIBB & SONS, L.L.C.56 apps

85%

Innate Tumor Immunity, Inc.25 apps

88%

Juno Therapeutics, Inc.24 apps

100%

MEDAREX, INC.13 apps

54%

AMIRA PHARMACEUTICALS, INC.7 apps

57%

Bars show the share of decided applications that were allowed.

Unlock the clients they file forIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Rejection fingerprint

What gets rejected, by statute

Share of parsed office actions raising each ground; blue is the USPTO.

Unlock the rejection fingerprintIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

What works

Allowance by strategy used

Unlock what works for this filerIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Interviews

Does an interview help?

Unlock the interview figuresFree with an account. No card needed.

Create a free account

Applications

Every application in the record

Application	Title	Filed	Status	Rejections	RCEs	To 1st action
19618852	CHIMERIC ANTIGEN RECEPTORS AND ANTIBODIES SPECIFIC FOR DELTA-LIKE LIGAND 3 (DLL3) A…	2026-08-26	Pending	0	0	n/a
19582554	UBIQUITIN SPECIFIC PROCESSING PROTEASE 1 (USP1) COMPOUNDS	2026-04-28	Pending	0	0	n/a
19582480	UBIQUITIN SPECIFIC PROCESSING PROTEASE 1 (USP1) COMPOUNDS	2026-04-28	Pending	0	0	n/a
15854280	Method and apparatus for adaptive signal processing	2012-01-10	Allowed	1	0	12.0 mo
15748835	Composition and method for controlled release	2015-02-11	Abandoned	4	1	23.0 mo
15966563	Distributed ledger transaction verification	2018-03-12	Allowed	3	0	20.0 mo
15159302	Thermal management of battery assemblies	2021-04-13	Pending	2	1	17.0 mo
15992149	Machine learning model for anomaly detection	2012-05-14	Allowed	1	0	14.0 mo
15484108	Wireless power transfer coil arrangement	2015-06-15	Abandoned	4	1	25.0 mo
15191444	Catalyst for selective hydrogenation	2018-07-16	Allowed	3	0	22.0 mo

Unlock all 2,349 applications, each with its full timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in